Schedule 13G ownership disclosure

Nuvectis Pharma Inc

Security class unavailable · CUSIP: 67080T108

Event date: 2022-12-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
16.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-23-002123
Form type
SC 13G/A
Filer
Mosseri Marlio Charles
CIK
CIK 1806384
Filed
Jan 09, 2023
Reporting period
Dec 30, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub